

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.16255822 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 5.02111368 |
| 3 | leukocyte aggregation (GO:0070486) | 4.58055174 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.57444224 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.57444224 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.40723136 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.40723136 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.40723136 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.40723136 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.40723136 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.40723136 |
| 12 | detection of other organism (GO:0098543) | 4.37709353 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.33420345 |
| 14 | response to peptidoglycan (GO:0032494) | 4.15853015 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 4.09282602 |
| 16 | detection of bacterium (GO:0016045) | 4.03502558 |
| 17 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.03150583 |
| 18 | response to muramyl dipeptide (GO:0032495) | 4.00694118 |
| 19 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.95811047 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80452435 |
| 21 | detection of external biotic stimulus (GO:0098581) | 3.79406785 |
| 22 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.75583153 |
| 23 | myeloid dendritic cell differentiation (GO:0043011) | 3.75179896 |
| 24 | tolerance induction (GO:0002507) | 3.74228531 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70154005 |
| 26 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.67499091 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 3.66018894 |
| 28 | microglial cell activation (GO:0001774) | 3.60475646 |
| 29 | detection of biotic stimulus (GO:0009595) | 3.54649811 |
| 30 | macrophage activation (GO:0042116) | 3.53138258 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.51854761 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.50366038 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 3.49796716 |
| 34 | myeloid dendritic cell activation (GO:0001773) | 3.49193280 |
| 35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.49000351 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.48126989 |
| 37 | positive regulation of humoral immune response (GO:0002922) | 3.44431368 |
| 38 | response to interleukin-15 (GO:0070672) | 3.44053658 |
| 39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43382633 |
| 40 | * myeloid cell activation involved in immune response (GO:0002275) | 3.39755601 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 3.38033763 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37644431 |
| 43 | response to host immune response (GO:0052572) | 3.37644431 |
| 44 | respiratory burst (GO:0045730) | 3.35000643 |
| 45 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34506606 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33579764 |
| 47 | B cell mediated immunity (GO:0019724) | 3.32852341 |
| 48 | negative regulation of cell killing (GO:0031342) | 3.31715146 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.31715146 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29519659 |
| 51 | negative thymic T cell selection (GO:0045060) | 3.28456700 |
| 52 | cellular extravasation (GO:0045123) | 3.27619961 |
| 53 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.27362782 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 3.23546335 |
| 55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.22885393 |
| 56 | regulation of interferon-alpha production (GO:0032647) | 3.22650237 |
| 57 | negative T cell selection (GO:0043383) | 3.21912606 |
| 58 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.21911983 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.21792443 |
| 60 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.20904778 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.20138399 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19332455 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.19105235 |
| 64 | leukocyte cell-cell adhesion (GO:0007159) | 3.17767205 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.17397518 |
| 66 | positive regulation of type 2 immune response (GO:0002830) | 3.17200622 |
| 67 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16554662 |
| 68 | response to host (GO:0075136) | 3.16554662 |
| 69 | response to host defenses (GO:0052200) | 3.16554662 |
| 70 | regulation of chronic inflammatory response (GO:0002676) | 3.16537399 |
| 71 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.15903267 |
| 72 | * neutrophil activation involved in immune response (GO:0002283) | 3.15005176 |
| 73 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.14707229 |
| 74 | response to type I interferon (GO:0034340) | 3.13841148 |
| 75 | cellular response to type I interferon (GO:0071357) | 3.12664738 |
| 76 | type I interferon signaling pathway (GO:0060337) | 3.12664738 |
| 77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12227475 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 3.12141143 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08386813 |
| 80 | positive regulation of interleukin-17 production (GO:0032740) | 3.06453338 |
| 81 | regulation of tolerance induction (GO:0002643) | 3.06450321 |
| 82 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.06044207 |
| 83 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.04178055 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03991383 |
| 85 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.03294609 |
| 86 | germinal center formation (GO:0002467) | 3.02731301 |
| 87 | T cell migration (GO:0072678) | 3.00723792 |
| 88 | defense response to protozoan (GO:0042832) | 3.00654158 |
| 89 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00646952 |
| 90 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.99796787 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.99679517 |
| 92 | * granulocyte activation (GO:0036230) | 2.99424227 |
| 93 | regulation of leukocyte degranulation (GO:0043300) | 2.99322289 |
| 94 | neutrophil mediated immunity (GO:0002446) | 2.98950610 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.98812258 |
| 96 | * neutrophil activation (GO:0042119) | 2.98259151 |
| 97 | regulation of natural killer cell differentiation (GO:0032823) | 2.98083800 |
| 98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.97747942 |
| 99 | T-helper 1 type immune response (GO:0042088) | 2.97702061 |
| 100 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.97695066 |
| 101 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.97274862 |
| 102 | natural killer cell mediated immunity (GO:0002228) | 2.97274862 |
| 103 | response to protozoan (GO:0001562) | 2.97146444 |
| 104 | positive regulation of mast cell degranulation (GO:0043306) | 2.96947085 |
| 105 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.96947085 |
| 106 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.96782986 |
| 107 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.95040385 |
| 108 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94044076 |
| 109 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93420957 |
| 110 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93148530 |
| 111 | cellular response to interleukin-15 (GO:0071350) | 2.92860409 |
| 112 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.90449006 |
| 113 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86557985 |
| 114 | growth hormone receptor signaling pathway (GO:0060396) | 2.86485065 |
| 115 | dendritic cell differentiation (GO:0097028) | 2.86214619 |
| 116 | positive regulation of interleukin-2 production (GO:0032743) | 2.86080475 |
| 117 | regulation of interleukin-12 production (GO:0032655) | 2.85959638 |
| 118 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.84990203 |
| 119 | myeloid leukocyte mediated immunity (GO:0002444) | 2.84566210 |
| 120 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.83716508 |
| 121 | negative regulation of interleukin-6 production (GO:0032715) | 2.82782568 |
| 122 | positive regulation of interleukin-12 production (GO:0032735) | 2.82083321 |
| 123 | positive regulation of heat generation (GO:0031652) | 2.81551685 |
| 124 | * myeloid leukocyte activation (GO:0002274) | 2.78405569 |
| 125 | regulation of RIG-I signaling pathway (GO:0039535) | 2.77439312 |
| 126 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.77340223 |
| 127 | regulation of necroptotic process (GO:0060544) | 2.77319346 |
| 128 | regulation of type 2 immune response (GO:0002828) | 2.77112685 |
| 129 | regulation of B cell differentiation (GO:0045577) | 2.76994951 |
| 130 | regulation of fever generation (GO:0031620) | 2.76885573 |
| 131 | positive regulation of macrophage differentiation (GO:0045651) | 2.76612179 |
| 132 | regulation of antigen processing and presentation (GO:0002577) | 2.75804482 |
| 133 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.74432959 |
| 134 | B cell receptor signaling pathway (GO:0050853) | 2.72910588 |
| 135 | leukocyte mediated cytotoxicity (GO:0001909) | 2.72116498 |
| 136 | cellular response to zinc ion (GO:0071294) | 2.71582585 |
| 137 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70854815 |
| 138 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.69924635 |
| 139 | positive regulation of B cell mediated immunity (GO:0002714) | 2.69924635 |
| 140 | cytokine secretion (GO:0050663) | 2.69542112 |
| 141 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.69525218 |
| 142 | regulation of growth of symbiont in host (GO:0044126) | 2.69525218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.99766725 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.81580152 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.62806664 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.44716472 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.11615862 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.59224587 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41809948 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.40290722 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.37971268 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.28552524 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.25348051 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.16709100 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16310375 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.15156774 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01724986 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.99540897 |
| 17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.87560687 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.79852441 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.70480671 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55572977 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.41636094 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.36170757 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.32467060 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21060004 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20220061 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.19439848 |
| 27 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.18996373 |
| 28 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.15118844 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14099409 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.10995078 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 2.04574385 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98431889 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98069040 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97840501 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89448820 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88836841 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86746425 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80258057 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80015387 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66020276 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56436907 |
| 42 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.55728014 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51589870 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49832286 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.48391299 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47332472 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47219123 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42076022 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40387197 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40079194 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.39679538 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38946339 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34030497 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32977128 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31753159 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30383966 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29805847 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29231659 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28710755 |
| 60 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28614650 |
| 61 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27453924 |
| 62 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24656537 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24002218 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23924766 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20984188 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20962534 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20313181 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16458420 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16272293 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15762966 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15095890 |
| 72 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14243458 |
| 73 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13539935 |
| 74 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.12432414 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07388435 |
| 76 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04911213 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04559225 |
| 78 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04508441 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03157140 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02221256 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01906584 |
| 82 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99601973 |
| 83 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98562208 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96452414 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96380506 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95784353 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95320607 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95092198 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95092136 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94977138 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94601171 |
| 92 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.90560567 |
| 93 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90026570 |
| 94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90026570 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89737292 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89163022 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88854796 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86900269 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86404309 |
| 100 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85295548 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84648360 |
| 102 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84464060 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83487086 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83133143 |
| 105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81554288 |
| 106 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81216682 |
| 107 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78245731 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77658563 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77540837 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77450862 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77079040 |
| 112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.77068091 |
| 113 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74691204 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72191496 |
| 115 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71212826 |
| 116 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.70261334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.93723757 |
| 2 | MP0003303_peritoneal_inflammation | 3.75372428 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.61157705 |
| 4 | MP0009785_altered_susceptibility_to | 3.52955458 |
| 5 | MP0000685_abnormal_immune_system | 3.36142825 |
| 6 | MP0001790_abnormal_immune_system | 3.05352118 |
| 7 | MP0005387_immune_system_phenotype | 3.05352118 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.94348321 |
| 9 | MP0005671_abnormal_response_to | 2.90597664 |
| 10 | MP0001800_abnormal_humoral_immune | 2.73469659 |
| 11 | MP0004510_myositis | 2.73237058 |
| 12 | MP0002419_abnormal_innate_immunity | 2.68211822 |
| 13 | MP0005025_abnormal_response_to | 2.67847075 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.67529534 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.57091079 |
| 16 | MP0003724_increased_susceptibility_to | 2.53776601 |
| 17 | MP0002723_abnormal_immune_serum | 2.48494709 |
| 18 | MP0001819_abnormal_immune_cell | 2.32378602 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.31694735 |
| 20 | MP0002405_respiratory_system_inflammati | 2.27771904 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.21151076 |
| 22 | MP0001853_heart_inflammation | 2.18409504 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.07703951 |
| 24 | MP0004947_skin_inflammation | 2.06884058 |
| 25 | MP0009278_abnormal_bone_marrow | 2.06082382 |
| 26 | MP0006082_CNS_inflammation | 2.03506853 |
| 27 | MP0010155_abnormal_intestine_physiology | 2.02019302 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.99386377 |
| 29 | MP0002398_abnormal_bone_marrow | 1.96707161 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.90966333 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.90460833 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.88309528 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.88182153 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.88182153 |
| 35 | MP0000716_abnormal_immune_system | 1.84336897 |
| 36 | MP0008004_abnormal_stomach_pH | 1.84262936 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.83720002 |
| 38 | MP0003448_altered_tumor_morphology | 1.76660696 |
| 39 | MP0005451_abnormal_body_composition | 1.75494596 |
| 40 | MP0002933_joint_inflammation | 1.74846192 |
| 41 | MP0002006_tumorigenesis | 1.74027940 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.72747485 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.68443702 |
| 44 | MP0000858_altered_metastatic_potential | 1.63380360 |
| 45 | MP0009764_decreased_sensitivity_to | 1.62511129 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.61677419 |
| 47 | MP0008260_abnormal_autophagy | 1.59593605 |
| 48 | MP0000343_altered_response_to | 1.59303095 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.59261320 |
| 50 | MP0002722_abnormal_immune_system | 1.57212770 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.55960656 |
| 52 | MP0002429_abnormal_blood_cell | 1.55097130 |
| 53 | MP0001873_stomach_inflammation | 1.46087228 |
| 54 | MP0008469_abnormal_protein_level | 1.41527932 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.37930838 |
| 56 | MP0002254_reproductive_system_inflammat | 1.28273750 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.26945105 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.26065418 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.23786019 |
| 60 | MP0005310_abnormal_salivary_gland | 1.22103759 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.21229642 |
| 62 | MP0004883_abnormal_blood_vessel | 1.19273638 |
| 63 | MP0002132_abnormal_respiratory_system | 1.18985619 |
| 64 | MP0005023_abnormal_wound_healing | 1.17497101 |
| 65 | MP0003075_altered_response_to | 1.16809738 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.12726820 |
| 67 | MP0003690_abnormal_glial_cell | 1.11945037 |
| 68 | MP0003866_abnormal_defecation | 1.09835265 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.09459454 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.09354866 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.08943019 |
| 72 | MP0000490_abnormal_crypts_of | 1.08664538 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.07429385 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.03822492 |
| 75 | MP0005390_skeleton_phenotype | 1.03111832 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.03009838 |
| 77 | MP0010307_abnormal_tumor_latency | 1.02317601 |
| 78 | MP0003091_abnormal_cell_migration | 1.02000282 |
| 79 | MP0001851_eye_inflammation | 1.01493693 |
| 80 | MP0003183_abnormal_peptide_metabolism | 0.99076407 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.95323589 |
| 82 | MP0003828_pulmonary_edema | 0.91580797 |
| 83 | MP0003279_aneurysm | 0.86540866 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.84356614 |
| 85 | MP0009840_abnormal_foam_cell | 0.84279917 |
| 86 | MP0009763_increased_sensitivity_to | 0.84021761 |
| 87 | MP0005166_decreased_susceptibility_to | 0.83360490 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.82533628 |
| 89 | MP0000604_amyloidosis | 0.81861394 |
| 90 | MP0005164_abnormal_response_to | 0.79410462 |
| 91 | MP0001348_abnormal_lacrimal_gland | 0.78473845 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.78303545 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.77518875 |
| 94 | MP0000249_abnormal_blood_vessel | 0.73093736 |
| 95 | MP0003795_abnormal_bone_structure | 0.71709058 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.70704058 |
| 97 | MP0004381_abnormal_hair_follicle | 0.67801873 |
| 98 | MP0002009_preneoplasia | 0.67124174 |
| 99 | MP0008874_decreased_physiological_sensi | 0.66388332 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.66010209 |
| 101 | MP0006054_spinal_hemorrhage | 0.64326759 |
| 102 | MP0001881_abnormal_mammary_gland | 0.63653186 |
| 103 | MP0001663_abnormal_digestive_system | 0.62382672 |
| 104 | MP0001958_emphysema | 0.62295982 |
| 105 | MP0008057_abnormal_DNA_replication | 0.60723895 |
| 106 | MP0005535_abnormal_body_temperature | 0.60147445 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.59968736 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.58437363 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57722199 |
| 110 | MP0001191_abnormal_skin_condition | 0.56991738 |
| 111 | MP0001243_abnormal_dermal_layer | 0.56848560 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.55663323 |
| 113 | MP0003045_fibrosis | 0.55441161 |
| 114 | MP0005621_abnormal_cell_physiology | 0.55184321 |
| 115 | MP0005165_increased_susceptibility_to | 0.51862582 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.51666889 |
| 117 | MP0004130_abnormal_muscle_cell | 0.50941945 |
| 118 | MP0000920_abnormal_myelination | 0.50850585 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.49019568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.75675889 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.08904852 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.39604856 |
| 4 | Myositis (HP:0100614) | 5.21710240 |
| 5 | Orchitis (HP:0100796) | 5.04529054 |
| 6 | Optic neuritis (HP:0100653) | 5.00296904 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.00296904 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.84861091 |
| 9 | Stomatitis (HP:0010280) | 4.82407496 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.69357241 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.68294884 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.56314428 |
| 13 | Recurrent viral infections (HP:0004429) | 3.78565271 |
| 14 | Recurrent skin infections (HP:0001581) | 3.74365392 |
| 15 | * Abnormality of macrophages (HP:0004311) | 3.74070196 |
| 16 | Obstructive lung disease (HP:0006536) | 3.69017588 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.69017588 |
| 18 | Vasculitis (HP:0002633) | 3.65459348 |
| 19 | Chronic otitis media (HP:0000389) | 3.60579086 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.59239798 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.59239798 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 3.59239798 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.57763799 |
| 24 | Gingivitis (HP:0000230) | 3.45907293 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 3.38776181 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 3.36358628 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.35248860 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.35248860 |
| 29 | Amyloidosis (HP:0011034) | 3.33131173 |
| 30 | Arterial thrombosis (HP:0004420) | 3.17131392 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.17075684 |
| 32 | Cellulitis (HP:0100658) | 3.16935569 |
| 33 | Meningitis (HP:0001287) | 3.13412261 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.03952581 |
| 35 | Hemoptysis (HP:0002105) | 3.00040002 |
| 36 | Leukocytosis (HP:0001974) | 2.96160230 |
| 37 | Episodic fever (HP:0001954) | 2.95916910 |
| 38 | Nasal polyposis (HP:0100582) | 2.94552004 |
| 39 | Petechiae (HP:0000967) | 2.90423766 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.90337513 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.88701358 |
| 42 | Increased IgM level (HP:0003496) | 2.87245773 |
| 43 | Urticaria (HP:0001025) | 2.87182172 |
| 44 | Recurrent bronchitis (HP:0002837) | 2.80725364 |
| 45 | Pustule (HP:0200039) | 2.80520460 |
| 46 | Gingival bleeding (HP:0000225) | 2.77970167 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.75588829 |
| 48 | Periodontitis (HP:0000704) | 2.75266147 |
| 49 | Increased IgE level (HP:0003212) | 2.69745190 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.68863074 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.68340872 |
| 52 | Loss of speech (HP:0002371) | 2.67594743 |
| 53 | Increased density of long bones (HP:0006392) | 2.67474064 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.66724865 |
| 55 | IgM deficiency (HP:0002850) | 2.63876039 |
| 56 | Peritonitis (HP:0002586) | 2.58743119 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.58392764 |
| 58 | Persistence of primary teeth (HP:0006335) | 2.54112678 |
| 59 | Abnormality of T cells (HP:0002843) | 2.53172486 |
| 60 | T lymphocytopenia (HP:0005403) | 2.52614833 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.52083916 |
| 62 | Osteomyelitis (HP:0002754) | 2.50228495 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.48744117 |
| 64 | Abnormal platelet volume (HP:0011876) | 2.48377129 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.45014362 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.44561277 |
| 67 | Encephalitis (HP:0002383) | 2.43878047 |
| 68 | Eosinophilia (HP:0001880) | 2.43292636 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.40537904 |
| 70 | Epistaxis (HP:0000421) | 2.39919898 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.37029435 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.34175489 |
| 73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34175489 |
| 74 | Myocardial infarction (HP:0001658) | 2.33807190 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.33756155 |
| 76 | Hematochezia (HP:0002573) | 2.32814041 |
| 77 | Vertigo (HP:0002321) | 2.31606027 |
| 78 | Thrombocytosis (HP:0001894) | 2.30607589 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30375051 |
| 80 | Hepatosplenomegaly (HP:0001433) | 2.29993541 |
| 81 | Joint swelling (HP:0001386) | 2.28258710 |
| 82 | Skin ulcer (HP:0200042) | 2.26482413 |
| 83 | IgA deficiency (HP:0002720) | 2.24500896 |
| 84 | Disinhibition (HP:0000734) | 2.23324349 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 2.22610567 |
| 86 | Glomerulopathy (HP:0100820) | 2.19601707 |
| 87 | Chest pain (HP:0100749) | 2.18290291 |
| 88 | Increased mean platelet volume (HP:0011877) | 2.17518466 |
| 89 | Granulocytopenia (HP:0001913) | 2.17435295 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15760060 |
| 91 | Tetraparesis (HP:0002273) | 2.14595814 |
| 92 | Emphysema (HP:0002097) | 2.14113869 |
| 93 | Colitis (HP:0002583) | 2.13833187 |
| 94 | Lymphopenia (HP:0001888) | 2.13089190 |
| 95 | Menorrhagia (HP:0000132) | 2.11301772 |
| 96 | Anorexia (HP:0002039) | 2.10001124 |
| 97 | Arthralgia (HP:0002829) | 2.09530776 |
| 98 | Amaurosis fugax (HP:0100576) | 2.08682286 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.08416948 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08294797 |
| 101 | Recurrent pneumonia (HP:0006532) | 2.07593438 |
| 102 | Purpura (HP:0000979) | 2.04630586 |
| 103 | Pulmonary embolism (HP:0002204) | 2.03883611 |
| 104 | Basal ganglia calcification (HP:0002135) | 2.02005704 |
| 105 | Chronic diarrhea (HP:0002028) | 2.00855678 |
| 106 | Fatigue (HP:0012378) | 2.00280166 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 1.99332453 |
| 108 | Gangrene (HP:0100758) | 1.98717111 |
| 109 | Abnormality of the pericardium (HP:0001697) | 1.98537327 |
| 110 | Abnormality of eosinophils (HP:0001879) | 1.98408153 |
| 111 | Increased cerebral lipofuscin (HP:0011813) | 1.98265939 |
| 112 | Vacuolated lymphocytes (HP:0001922) | 1.98044166 |
| 113 | Cheilitis (HP:0100825) | 1.96371457 |
| 114 | Sepsis (HP:0100806) | 1.95410783 |
| 115 | Keratitis (HP:0000491) | 1.95298992 |
| 116 | Restrictive lung disease (HP:0002091) | 1.95133013 |
| 117 | Acne (HP:0001061) | 1.94881254 |
| 118 | Abnormal platelet function (HP:0011869) | 1.94697131 |
| 119 | Impaired platelet aggregation (HP:0003540) | 1.94697131 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94167602 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94167602 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94167602 |
| 123 | Abnormality of the pleura (HP:0002103) | 1.92871751 |
| 124 | Recurrent lower respiratory tract infections (HP:0002783) | 1.92691116 |
| 125 | Premature loss of primary teeth (HP:0006323) | 1.89646797 |
| 126 | Thrombophlebitis (HP:0004418) | 1.89388555 |
| 127 | Abnormality of the endocardium (HP:0004306) | 1.85159558 |
| 128 | Polyneuropathy (HP:0001271) | 1.82571540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.22635160 |
| 2 | MAP4K1 | 3.45862338 |
| 3 | JAK3 | 3.37833754 |
| 4 | TBK1 | 3.27377859 |
| 5 | TXK | 3.18370214 |
| 6 | TYK2 | 3.10858583 |
| 7 | IRAK4 | 2.86480675 |
| 8 | PRPF4B | 2.77934290 |
| 9 | EPHB1 | 2.60573657 |
| 10 | IKBKE | 2.56039992 |
| 11 | IKBKB | 2.47819654 |
| 12 | IRAK3 | 2.27766024 |
| 13 | JAK1 | 2.14718937 |
| 14 | BLK | 2.09244651 |
| 15 | ZAP70 | 1.99088062 |
| 16 | STK10 | 1.98271724 |
| 17 | BMPR2 | 1.93735591 |
| 18 | TRIB3 | 1.84041613 |
| 19 | CHUK | 1.79067786 |
| 20 | FGFR4 | 1.74970626 |
| 21 | ERN1 | 1.72566952 |
| 22 | RPS6KA4 | 1.70118788 |
| 23 | RIPK4 | 1.69294960 |
| 24 | CSK | 1.66154512 |
| 25 | BTK | 1.65643000 |
| 26 | EPHA3 | 1.62979117 |
| 27 | KIT | 1.57395257 |
| 28 | TEC | 1.52665246 |
| 29 | MAP3K13 | 1.48322714 |
| 30 | ITK | 1.48092620 |
| 31 | TNK2 | 1.44777043 |
| 32 | HCK | 1.41980581 |
| 33 | MAP2K3 | 1.36026759 |
| 34 | GRK7 | 1.35837004 |
| 35 | IRAK2 | 1.34437257 |
| 36 | TAOK3 | 1.30635299 |
| 37 | PIM1 | 1.27694611 |
| 38 | FGFR3 | 1.27552872 |
| 39 | SYK | 1.26896458 |
| 40 | PIM2 | 1.25668368 |
| 41 | LRRK2 | 1.24863104 |
| 42 | MAP3K10 | 1.24154208 |
| 43 | GRK6 | 1.21316909 |
| 44 | LCK | 1.20450068 |
| 45 | JAK2 | 1.16657731 |
| 46 | PTK6 | 1.09378485 |
| 47 | MAP3K3 | 1.07380030 |
| 48 | TRPM7 | 1.04140393 |
| 49 | MST4 | 0.98874737 |
| 50 | NME2 | 0.98330647 |
| 51 | RIPK1 | 0.97545867 |
| 52 | TTN | 0.97220917 |
| 53 | CSF1R | 0.91081638 |
| 54 | CLK1 | 0.88198472 |
| 55 | CDC42BPA | 0.86690939 |
| 56 | FES | 0.85063215 |
| 57 | KSR2 | 0.82697653 |
| 58 | PKN2 | 0.81031773 |
| 59 | PDK1 | 0.80977593 |
| 60 | MARK3 | 0.80822640 |
| 61 | LYN | 0.79794560 |
| 62 | YES1 | 0.79334698 |
| 63 | FGR | 0.78929947 |
| 64 | TGFBR2 | 0.77976873 |
| 65 | PIK3CG | 0.77392618 |
| 66 | NEK9 | 0.77369499 |
| 67 | MAP3K11 | 0.76930035 |
| 68 | BMX | 0.75058450 |
| 69 | EEF2K | 0.74678587 |
| 70 | SIK2 | 0.74666980 |
| 71 | CDK12 | 0.74413748 |
| 72 | ALK | 0.73479425 |
| 73 | MAPK7 | 0.73113271 |
| 74 | IRAK1 | 0.72393702 |
| 75 | PDPK1 | 0.68862518 |
| 76 | NLK | 0.68143573 |
| 77 | MARK2 | 0.67956546 |
| 78 | MAPKAPK2 | 0.66229150 |
| 79 | KDR | 0.65909686 |
| 80 | TAOK1 | 0.63367224 |
| 81 | MAP3K8 | 0.62946252 |
| 82 | MAPK12 | 0.60766108 |
| 83 | STK4 | 0.59036782 |
| 84 | EGFR | 0.57164064 |
| 85 | MAP3K6 | 0.56927287 |
| 86 | TESK2 | 0.56589355 |
| 87 | FLT3 | 0.55939200 |
| 88 | SIK3 | 0.55250060 |
| 89 | DDR2 | 0.51258212 |
| 90 | PAK4 | 0.50520631 |
| 91 | FYN | 0.50468090 |
| 92 | MAP3K5 | 0.50429148 |
| 93 | PTK2B | 0.50408361 |
| 94 | PRKCQ | 0.49705564 |
| 95 | ABL1 | 0.45582299 |
| 96 | DAPK2 | 0.45424624 |
| 97 | CDK6 | 0.43264104 |
| 98 | MATK | 0.42129043 |
| 99 | NEK2 | 0.42055558 |
| 100 | MAP3K1 | 0.41803413 |
| 101 | SCYL2 | 0.41081651 |
| 102 | EIF2AK2 | 0.40825356 |
| 103 | PRKG2 | 0.40515192 |
| 104 | RPS6KA5 | 0.39954013 |
| 105 | SGK3 | 0.39617767 |
| 106 | PRKCD | 0.37596415 |
| 107 | RPS6KC1 | 0.37542943 |
| 108 | RPS6KL1 | 0.37542943 |
| 109 | PRKD2 | 0.37526510 |
| 110 | CAMKK2 | 0.37523364 |
| 111 | TESK1 | 0.35525361 |
| 112 | RPS6KA6 | 0.35204901 |
| 113 | DYRK1B | 0.34022815 |
| 114 | ABL2 | 0.33128612 |
| 115 | MOS | 0.32989838 |
| 116 | MAP2K6 | 0.32792243 |
| 117 | RPS6KA1 | 0.32557234 |
| 118 | HIPK2 | 0.31556215 |
| 119 | MAPK4 | 0.31080525 |
| 120 | STK3 | 0.30050606 |
| 121 | CDK4 | 0.30003790 |
| 122 | DMPK | 0.28964644 |
| 123 | STK24 | 0.28859658 |
| 124 | CDK19 | 0.26898674 |
| 125 | PDGFRB | 0.26792165 |
| 126 | MAP3K2 | 0.26375061 |
| 127 | ARAF | 0.26075636 |
| 128 | INSR | 0.25038761 |
| 129 | SIK1 | 0.24691929 |
| 130 | RAF1 | 0.24642686 |
| 131 | PRKCH | 0.23809758 |
| 132 | TAOK2 | 0.23455262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.29403191 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.00214470 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78187203 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.57825198 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45092945 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44277905 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.37027449 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.28223453 |
| 9 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.22003755 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.16839214 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.14922760 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.11552505 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.01485113 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.99741042 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.93558196 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.92543622 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.90065759 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81813202 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80912771 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80066673 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.79380506 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69812928 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.69773772 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.69724575 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68992150 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68496969 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.66937380 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65195917 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.62794257 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62778948 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.59748200 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47758941 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47717284 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46625827 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45670466 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.44123607 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42930514 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41957765 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37994773 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37016915 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33538180 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26242833 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.24723640 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24549822 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17084801 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16487054 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03917866 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03583377 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.01943111 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00933762 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98797004 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97138939 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93862888 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93382078 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90960656 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90092404 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88424011 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.85785868 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83878944 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.83006399 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.81398482 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80133627 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77520549 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76716878 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73185736 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.64745230 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63723868 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61817091 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58915597 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56814786 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.52257572 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51384021 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51355715 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49326897 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48741225 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47749114 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47599026 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45302005 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45257838 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45236044 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44846576 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43783007 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41972762 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41309777 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41166518 |
| 86 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40899769 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40249766 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.38991709 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38067665 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36900793 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36703129 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36702970 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.35574969 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35438135 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35153665 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.34270122 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34008685 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33768059 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.33442430 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33372296 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32931603 |
| 102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32583886 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29059408 |
| 104 | DNA replication_Homo sapiens_hsa03030 | 0.28155796 |
| 105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.28047887 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27171570 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.26844529 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26030045 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25851294 |
| 110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24540736 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23612547 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21937184 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.17802355 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.16345103 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.14080448 |

